There is no more compelling case for national health reform than cancer treatment and survivorship. Half of all men and more than one-third of all women will be diagnosed with cancer during their lifetimes [1]. There are more than 13 million cancer survivors in the USA with approximately 1.4 million new cases of cancer diagnosed annually [2]. As a result of earlier detection, improved therapies, and increased attention to treatment sequelae, more patients are in need of cancer treatment and follow-up care than ever before. Five-year survival rates for all cancers diagnosed between 1999 and 2005 reached 68%, up from 50% during the 1975–1977 time period [1]. In addition to an ever-increasing patient pool, cancer survivors are living longer and in need of more comprehensive follow-up care over a longer period of time.